Literature Review of Publications on Population-Based APTACs and IDIFs
Reference | n | Method | Calibration | AUC | MRglc |
---|---|---|---|---|---|
Takikawa et al. (13) | 10/24 | Arithmetic mean | 2 arterial | 0.998 | 0.992 |
1 AVS | 0.998 | 0.989 | |||
Tsuchida et al. (14) | 44/10 | Arithmetic mean | — | +3.5% ± 2.2% | +2.9% ± 1.9% |
Shiozaki et al. (15) | 101/192 | Arithmetic mean | AA/iDV | +7.2% ± 5.7% | +8.9% ± 7.3% |
Bentourkia et al. (29) | 20/same 20 | Fit to equation | — | — | 0.998 |
Eberl et al. (17) | 26/26 | Fit to equation | 2 AVS | — | 0.995 |
de Geus-Oei et al. (9) | 136 | IDIF | — | — | 0.98 |
This study | 80/40 | Fit to equation | AA/iDV | 0.880 | 0.963 |
1 arterial | 0.994 | 0.994 | |||
IDIF | — | 0.856 | 0.966 |
n = no. of patients (to derive curve/to validate curve); AUC = correlation or mean % difference between AUC of population-based curve and serial arterial sampling; MRglc = correlation or mean % difference between glucose metabolic rate of population-based curve and serial arterial sampling; AVS = arterialized venous samples; AA/iDV = administered activity/initial distribution volume of 18F-FDG.